Molecule Details
| InChIKey | UNRHXEPDKXPRTM-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.23 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB13273 |
|---|---|
| Drug Name | Sultopride |
| CAS Number | 53583-79-2 |
| Groups | approved |
| ATC Codes | N05AL02 |
| Description | Sultopride is used in Japan, Hong Kong, and Europe to treat schizophrenia. It is of the drug class atypical antipsychotics [L5626]. |
Categories: Acids, Carbocyclic Amides Antidepressive Agents Antidepressive Agents, Second-Generation Antipsychotic Agents Benzamides and benzamide derivatives Benzene Derivatives Benzoates Central Nervous System Agents Central Nervous System Depressants Dopamine Agents Dopamine Antagonists Moderate Risk QTc-Prolonging Agents Nervous System Neurotoxic agents Neurotransmitter Agents Psycholeptics Psychotropic Drugs QTc Prolonging Agents Tranquilizing Agents
Cross-references: BindingDB: 86720 ChEBI: 9356 CHEMBL277945 ChemSpider: 5164 C11708 RxCUI: 37416 Wikipedia: Sultopride